Heart Health Center
Select a Health Center
Latest Headlines
New Debate Over Vytorin and Cancer
Although two new trials failed to show a cancer link for Vytorin, the cholesterol-lowering drug isn't ready to be completely cleared, the editor of the New England Journal of Medicine says.
Although two new trials failed to show a cancer link for Vytorin, the cholesterol-lowering drug isn't ready to be completely cleared, the editor of the New England Journal of Medicine says.



